Ignite Creation Date:
2025-12-25 @ 3:29 AM
Ignite Modification Date:
2026-04-22 @ 3:24 AM
Study NCT ID:
NCT02556905
Status:
COMPLETED
Last Update Posted:
2017-12-04
First Post:
2015-09-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Collect and Evaluate the Safety and Efficacy Information of Korean Multiple Myeloma Patients Treated With REVLIMID®, After Approval of Marketing Authorization for New Drug in Korea
Sponsor:
Celgene
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Multiple Myeloma | View |